Toluene → 2-(5-Isopropylisochroman-1-yl)-4,5-dihydro-1H-imidazole
Reaction equation
Br[C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH2:4][CH2:5][O:6][CH:7]2[C:12]1[NH:13][CH2:14][CH2:15][N:16]=1.[C:17](P(C(C)(C)C)C(C)(C)C)(C)([CH3:19])[CH3:18].C1(C)C=CC=CC=1.[Br-].C([Zn+])(C)C>C1COCC1.C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH:17]([C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH2:4][CH2:5][O:6][CH:7]2[C:12]1[NH:13][CH2:14][CH2:15][N:16]=1)([CH3:19])[CH3:18]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 2-(5-bromoisochroman-1-yl)-4,5-dihydro-1H-imidazole (0.25 g, synthesis method A), palladium(II) acetate (0.01 g), tri-tert-butylphosphine (0.044 ml) and toluene (3 ml) in ice bath temperature was added 6.22 ml of 0.5M isopropyl zinc bromide in THF, and stirred at ambient temperature for 3 hrs. The reaction was quenched with dilute hydrochloric acid, and the organic phase was separated. The aqueous phase was made alkaline with 1M NaOH, and purified with separation methods A and G to yield the title compound. (Yield 2 mg).
Workup
- customThe reaction was quenched with dilute hydrochloric acid
- customthe organic phase was separated
- custompurified with separation methods A and G
Sources & evidence
- ORD record
- ord-e6cd09a571514c8db5ca159af08104ca
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09249127B2
Reaction notes
Loading…